Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma - Drug Trials For Money - Paid Clinical Trials

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Conditions:   Melanoma;   Advanced Melanoma
Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection
Sponsors:   University of California, San Francisco;   Merck Sharp & Dohme Corp.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 4, 2021 / by / in
Comments